Explore how AI-driven multiomics is reshaping drug discovery and personalized medicine development through innovative data ...
Morning Overview on MSN
Scientists link 2 cancer hallmarks in a way no one expected
Cancer researchers have long treated genetic chaos and epigenetic rewiring as separate engines of disease, two parallel ...
News-Medical.Net on MSN
First human 'lung-on-chip' model developed using stem cells from a single donor
Researchers at the Francis Crick Institute and AlveoliX have developed the first human 'lung-on-chip' model using stem cells ...
The chip can simulate breathing and lung disease for an individual, holding promise for testing personalized treatments for tuberculosis.
A new method for engineering natural killer cells could make cancer immunotherapy more efficient, scalable, and affordable, potentially reshaping how these treatments are produced.
Trethera Corp. received a $2.7M NIH grant to study combining TRE-515 with KRAS inhibitors for lung cancer. Learn how this ...
About Xtract One Technologies Inc. Xtract One Technologies, Inc. engages in commercializing an integrated, layered, multi-sensor platform of technologies with the aim of enhancing public safety. It ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback